Evaluation of all-cause mortality and cardiovascular safety in patients receiving chimeric antigen receptor T cell therapy: a prospective cohort studyResearch in context

Summary: Background: Assessment of cardiovascular risk is critical for patients with cancer. Previous retrospective studies suggest potential cardiotoxicity of CAR T cell therapies. We aimed to prospectively assess cardiotoxicity and the predictive value of cardiac biomarkers and classical risk fac...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Felix Korell, Lukas Entenmann, Sebastian Romann, Evangelos Giannitsis, Anita Schmitt, Carsten Müller-Tidow, Norbert Frey, Peter Dreger, Michael Schmitt, Lorenz H Lehmann
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: Elsevier 2024-03-01
Loạt:EClinicalMedicine
Những chủ đề:
Truy cập trực tuyến:http://www.sciencedirect.com/science/article/pii/S258953702400083X